Skip to main content

Table 2 General characteristics and significant findings of ketogenic diet in association with gut microbiota and neurological diseases in clinical-trial studies

From: Does the ketogenic diet improve neurological disorders by influencing gut microbiota? A systematic review

First author, (Year)

Country

Study design

Study population

Sample size

Intervention group

Control group

Duration

Microbiota analysis method

Changes on microbiota or metabolites derive

Clinical outcomes

Ferraris C., et al. (2021) [12]

Italy

Single-arm, uncontrolled, quasi experimental

Patients with epilepsy

Age:

2-46 yr

Male:3

Female:4

N = 7

N = 7

N.A

One month

Cytotoxicity, genotoxicity, measuring SCFA

Decrease in fecal SCFA, (acetate, propionate, butyrate), isobutyrate

Decrease in seizures attacks (> 50%) and involuntary movements

Bahr L., et al. (2018) [22]

Germany

Single-center, randomized, controlled, parallel-group study

Patients with relapsing–remitting MS

Age:

18-65 yr

Male:

N.A

Female:

N.A

N = 111 (37 patients in each KD, FD and SD groups)

N = 74 (37 patients in KD group and 37 patients in FD group)

N = 37

Nine months

Biochemical measures

Increase in serum beta hydroxybutyrate level

Improve cognition in KD group

Lee R., et al. (2018) [14]

United States

Open-label, observer-blinded, quasi experimental

children with ASD

Mean age: 7.9 ± 3.3 yr

Male:13

Female:2

N = 15

N = 15

N.A

Three months

Biochemical measures

Increase in serum beta hydroxybutyrate level

Improve behaviors

Swidsinski A., et al. (2017) [15]

Germany

Controlled, randomized clinical trials

Patients with MS

Mean age: N.A

Male: N.A

Female: N.A

N = 24 (10 patients in KD and 14 patients in control group)

N = 10

N = 14

Six months

FISH with ribosomal RNA derived probs

Decrease in pioneer bacterial groups, increase in Akkermansia

Positive effects on MS patients

Xie G., et al. (2017) [16]

China

Controlled, randomized clinical trials

Children with epilepsy

Mean age: 1.95 ± 3.1 yr

Male: 11

Female: 3

N = 44 (14 patients in KD group and 30 healthy infants in control group)

N = 14

N = 30

One week

16 s rRNA sequencing

Decrease in Proteobacteria Cronobacter, no change in Bacteroides, increase in Prevotella, Bifidobacterium

Clinical improvement (64%), decrease in seizure frequency (50%)

Tagliabue A., et al. (2016) [17]

Italy

Prospective, single-center, single-arm quasi experimental

Epileptic patients affected by GLUT1 DS

Age:

8-34 yr

Male:3

Female:3

N = 6

N = 6

N.A

Three months

RT-PCR and bacterial DNA extraction

Increase in Desulfovibrio spp.

No change

  1. KD Ketogenic diet, FD Fasting diet, SD Standard diet, MS Multiple Sclerosis, SCFA Short chain fatty acid, FISH Fluorescence in situ hybridization, RT-PCR Real time polymerase chain reaction, GLUT1DS Glucose transporter type 1 deficiency syndrome, RNA Ribonucleic acid, DNA Deoxyribonucleic acid, ASD Autism Spectrum disorder